Search Keyword

[Current location in website]

Global Top > News Release > Kyowa Hakko News Release

April 23rd, 2001

Kyowa Hakko Starts Marketing
Cholesterol-Lowering Super Soy in the U.S., Europe

 Kyowa Hakko, a leading Japanese pharmaceutical and biotechnology company, announced it will start marketing in the U.S. and Europe CSPHP super soy, a food ingredient that has been made to enhance the natural, cholesterol-lowering properties of soy.

 To create CSPHP, Kyowa Hakko has for the first time combined soy protein hydrolyzate with phospholipids, creating an ingredient that can be added to a wide variety of food products, which in turn will inhibit the body's absorption of cholesterol.

 CSPHP is acknowledged by Japan's Ministry of Health, Labor and Welfare to be a Food for Specified Health Use and provides consumers around the world with a natural, cost-effective way to lower cholesterol.

 According to the U.S. Food and Drug Administration, excess cholesterol is one of the main causes of heart disease, a condition that costs the U.S. economy roughly $60 billion in lost productivity and medical expenses a year, and is the main cause of death in the U.S.

 A 3-gram dose of CSPHP taken daily for one month reduced the LDL-cholesterol level of volunteers by 17 percent, whereas the 25-gram daily dose of regular soy the FDA recommends reduces cholesterol by only 10 percent. Furthermore, the same dosage of CSPHP increased HDL-cholesterol by 14 percent.

 "This health food ingredient dramatically lowers a body's serum-cholesterol levels," said Tadayasu Furukawa, executive officer from Kyowa Hakko's Food Company. "Of course soy is a natural product, which means it's safe to include in your everyday diet. "

 Since CSPHP is heat-resistant, pH-neutral and stable when mixed with other food ingredients, it provides food producers with a safe, cost-effective ingredient they can add to a wide range of products and manufacturing processes. Alternatively, CSPHP can be taken in powder or tablet form as a dietary supplement.

 About Kyowa Hakko - World leaders in fermentation, biotechnology, and chemical synthesis, Kyowa Hakko develops, manufactures and markets pharmaceuticals, amino acids, nucleic acids, fine chemicals, and food ingredients. Backed by more than half a century of manufacturing innovation, advanced technology, and a commitment to research, Kyowa Hakko's products are known for high quality, reliability and cost-effectiveness.


For more information, please contact
Corporate Communications Department
KYOWA HAKKO KOGYO CO., LTD.
1-6-1 Ohtemachi, Chiyoda-ku
Tokyo 100-8185 JAPAN
E-mail pr@kyowa.co.jp
URL http://www.kyowa.co.jp

Alternatively, please contact
Kyowa Hakko U.S.A., Inc.
Marketing Department,
599 Lexington Avenue,
Suite 4103, New York, NY 10022,U.S.A.
TEL +1-212-319-5353
FAX +1-212-421-1283

Or Kyowa Hakko's West Coast office,
85 Enterprise, Suite 430,
Aliso Viejo, California 92656,U.S.A.
TEL +1-949-425-0707
FAX +1-949-425-0708

Kyowa Europe GmBH
Immermannstrasse -3, D-40210
Dusseldorf, Germany
TEL +49-211-17-728-0
FAX +49-211-17-728-41



Return
Features

New window opens

New window opens: Antibody Technology